Cancer Prevention in Primary Care: Perception of Importance, Recognition of Risk Factors and Prescribing Behaviors

Author:

Samimi Goli,Heckman-Stoddard Brandy M.,Holmberg Christine,Tennant Bethany,Sheppard Bonny Bloodgood,Coa Kisha I.,Kay Shelley S.,Ford Leslie G.,Szabo EvaORCID,Minasian Lori M.

Funder

National Cancer Institute

Publisher

Elsevier BV

Subject

General Medicine

Reference43 articles.

1. Molecular cancer prevention: current status and future directions;Maresso;CA Cancer J Clin,2015

2. Benefit/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 50 years or older;Freedman;J Clin Oncol,2011

3. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality;Domchek;JAMA,2010

4. Oral contraceptive use for the primary prevention of ovarian cancer;Havrilesky;Evid Rep Technol Assess (Full Rep),2013

5. The chemoprevention of ovarian cancer: the need and the options;Kathawala;Curr Pharmacol Rep,2018

Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3